Compare HIPO & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HIPO | IART |
|---|---|---|
| Founded | 2015 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 907.5M | 951.9M |
| IPO Year | 2020 | 1996 |
| Metric | HIPO | IART |
|---|---|---|
| Price | $37.71 | $14.10 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 12 |
| Target Price | ★ $44.00 | $15.67 |
| AVG Volume (30 Days) | 261.3K | ★ 1.1M |
| Earning Date | 10-29-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 235.37 | N/A |
| EPS | ★ 0.98 | 0.19 |
| Revenue | ★ $468,600,000.00 | N/A |
| Revenue This Year | $25.50 | $0.55 |
| Revenue Next Year | $32.25 | $1.86 |
| P/E Ratio | ★ $38.73 | $73.58 |
| Revenue Growth | ★ 25.93 | N/A |
| 52 Week Low | $24.08 | $8.70 |
| 52 Week High | $39.39 | $20.49 |
| Indicator | HIPO | IART |
|---|---|---|
| Relative Strength Index (RSI) | 63.99 | 51.45 |
| Support Level | $24.68 | $11.96 |
| Resistance Level | $39.39 | $14.28 |
| Average True Range (ATR) | 1.42 | 0.78 |
| MACD | -0.02 | 0.20 |
| Stochastic Oscillator | 79.60 | 64.61 |
Hippo Holdings Inc is a home insurance group that created a new standard of care and protection for homeowners. It provides insurance for computers, home offices, electronics, appliances, water backup, and service line coverage, among others. It has three reportable segments Services segment earns fees and commission income without assuming underwriting risk or need for reinsurance, Insurance-as-a-Service managed through the company's subsidiary Spinnaker is a platform to support third-party MGAs, and the Hippo Home Insurance Program engaged in homeowners insurance business. It generates the majority of its revenue from the Insurance-as-a-Service segment.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.